Clinical Trial Update: Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders [NA]

View source ↗

Summary

This clinical trial update documents the status of a non-myeloablative allogeneic transplant trial for myelodysplastic syndromes and myeloproliferative disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Snippet

Sponsor: Stanford University | Conditions: Myelodysplastic Syndromes, Myeloproliferative Disorders | NA | Status: COMPLETED